Compared to the CK treatment, BC1, BC2, and WV1 decreased by 22.44, 18.82, and 21.91%, respectively, while the high-dose WV2 alone and its combined application with high-dose BC increased S-CAT activity. Here, CAT is linked to breast cancer.